{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:24:54Z","timestamp":1792445094222,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40121-025-01295-z","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:54:41Z","timestamp":1774515281000},"page":"1353-1367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Outcomes Among Older Adults Hospitalized with Respiratory Syncytial Virus and Influenza Infection: A Retrospective Analysis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7167-384X","authenticated-orcid":false,"given":"Menucha","family":"Jurkowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ili","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arad","family":"Teper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Royzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Begier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imri","family":"Ganiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mandelboim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"1295_CR1","doi-asserted-by":"publisher","unstructured":"Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749\u201359. https:\/\/doi.org\/10.1056\/NEJMoa043951.","DOI":"10.1056\/NEJMoa043951"},{"issue":"11","key":"1295_CR2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger C, Blacker B, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191\u2013210.","journal-title":"Lancet Infect Dis"},{"key":"1295_CR3","doi-asserted-by":"crossref","unstructured":"Nguyen-Van-Tam JS, O\u2019Leary M, Martin ET, et al. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Eur Respir Rev. 2022;31(166):220105.","DOI":"10.1183\/16000617.0105-2022"},{"issue":"2","key":"1295_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0527","volume":"5","author":"CL Hansen","year":"2022","unstructured":"Hansen CL, Chaves SS, Demont C, Viboud C. Mortality associated with influenza and respiratory syncytial virus in the US, 1999\u20132018. JAMA Netw Open. 2022;5(2):e220527.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"1295_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S2213-2600(24)00255-8","volume":"12","author":"JG Wildenbeest","year":"2024","unstructured":"Wildenbeest JG, Lowe DM, Standing JF, Butler CC. Respiratory syncytial virus infections in adults: a narrative review. Lancet Respir Med. 2024;12(10):822\u201336.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"1295_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.44756","volume":"7","author":"FP Havers","year":"2024","unstructured":"Havers FP, Whitaker M, Melgar M, et al. Burden of respiratory syncytial virus-associated hospitalizations in us adults, October 2016 to September 2023. JAMA Netw Open. 2024;7(11):e2444756.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1295_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/QCO.0000000000001000","volume":"37","author":"S Kenmoe","year":"2024","unstructured":"Kenmoe S, Nair H. The disease burden of respiratory syncytial virus in older adults. Curr Opin Infect Dis. 2024;37(2):129\u201336.","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"1295_CR8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s40121-023-00792-3","volume":"12","author":"Y Li","year":"2023","unstructured":"Li Y, Kulkarni D, Begier E, et al. Adjusting for case under-ascertainment in estimating RSV hospitalisation burden of older adults in high-income countries: a systematic review and modelling study. Infect Dis Ther. 2023;12(4):1137\u201349.","journal-title":"Infect Dis Ther"},{"issue":"7","key":"1295_CR9","doi-asserted-by":"publisher","first-page":"ofac300","DOI":"10.1093\/ofid\/ofac300","volume":"9","author":"JM McLaughlin","year":"2022","unstructured":"McLaughlin JM, Khan F, Begier E, Swerdlow DL, Jodar L, Falsey AR. Rates of medically attended RSV among US adults: a systematic review and meta-analysis. Open Forum Infect Dis. 2022;9(7):ofac300.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"1295_CR10","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/irv.13031","volume":"17","author":"M Savic","year":"2023","unstructured":"Savic M, Penders Y, Shi T, Branche A, Pir\u00e7on JY. Respiratory syncytial virus disease burden in adults aged 60\u00a0years and older in high-income countries: a systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1):e13031.","journal-title":"Influenza Other Respir Viruses"},{"issue":"9","key":"1295_CR11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/pathogens13090750","volume":"13","author":"T Brosh-Nissimov","year":"2024","unstructured":"Brosh-Nissimov T, Ostrovsky D, Cahan A, et al. Adult respiratory syncytial virus infection: defining incidence, risk factors for hospitalization, and poor outcomes, a regional cohort study, 2016\u20132022. Pathogens. 2024;13(9):750.","journal-title":"Pathogens"},{"key":"1295_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf204","author":"E Begier","year":"2025","unstructured":"Begier E, Aliabadi N, Ramirez JA, et al. Detection by nasopharyngeal swabs alone underestimates respiratory syncytial virus-related hospitalization incidence in adults: the multispecimen study\u2019s final analysis. J Infect Dis. 2025. https:\/\/doi.org\/10.1093\/infdis\/jiaf204.","journal-title":"J Infect Dis"},{"issue":"2","key":"1295_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/infdis\/jiad012","volume":"228","author":"C Onwuchekwa","year":"2023","unstructured":"Onwuchekwa C, Moreo LM, Menon S, et al. Underascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations: a systematic literature review and meta-analysis. J Infect Dis. 2023;228(2):173\u201384.","journal-title":"J Infect Dis"},{"issue":"6","key":"1295_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s40121-023-00802-4","volume":"12","author":"MH Rozenbaum","year":"2023","unstructured":"Rozenbaum MH, Begier E, Kurosky SK, et al. Incidence of respiratory syncytial virus infection in older adults: limitations of current data. Infect Dis Ther. 2023;12(6):1487\u2013504.","journal-title":"Infect Dis Ther"},{"issue":"Suppl_1","key":"1295_CR15","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1093\/infdis\/jiab452","volume":"226","author":"K Korsten","year":"2022","unstructured":"Korsten K, Adriaenssens N, Coenen S, et al. World Health Organization influenza-like illness underestimates the burden of respiratory syncytial virus infection in community-dwelling older adults. J Infect Dis. 2022;226(Suppl_1):S71\u20138.","journal-title":"J Infect Dis"},{"issue":"29","key":"1295_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","volume":"72","author":"M Melgar","year":"2023","unstructured":"Melgar M, Britton A, Roper LE, et al. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(29):793\u2013801.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"1295_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/irv.12249","volume":"8","author":"T Meningher","year":"2014","unstructured":"Meningher T, Hindiyeh M, Regev L, Sherbany H, Mendelson E, Mandelboim M. Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses. Influenza Other Respir Viruses. 2014;8(4):422\u201330.","journal-title":"Influenza Other Respir Viruses"},{"issue":"12","key":"1295_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226403","volume":"14","author":"L Folgueira","year":"2019","unstructured":"Folgueira L, Moral N, Pascual C, Delgado R. Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples. PLoS ONE. 2019;14(12):e0226403.","journal-title":"PLoS ONE"},{"issue":"3","key":"1295_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1\u201367.","journal-title":"J Stat Softw"},{"issue":"6","key":"1295_CR20","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.chest.2021.12.670","volume":"161","author":"J Coussement","year":"2022","unstructured":"Coussement J, Zuber B, Garrigues E, et al. Characteristics and outcomes of patients in the ICU with respiratory syncytial virus compared with those with influenza infection: a multicenter matched cohort study. Chest. 2022;161(6):1475\u201384.","journal-title":"Chest"},{"issue":"4","key":"1295_CR21","doi-asserted-by":"publisher","first-page":"E244954","DOI":"10.1001\/jamanetworkopen.2024.4954","volume":"7","author":"D Surie","year":"2024","unstructured":"Surie D, Yuengling KA, Decuir J, et al. Severity of respiratory syncytial virus vs COVID-19 and influenza among hospitalized US adults. JAMA Netw Open. 2024;7(4):E244954.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1295_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cmi.2016.11.014","volume":"23","author":"P Loubet","year":"2017","unstructured":"Loubet P, Lenzi N, Valette M, et al. Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France. Clin Microbiol Infect. 2017;23(4):253\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"96","key":"1295_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcv.2017.09.001","volume":"1","author":"RE Malosh","year":"2017","unstructured":"Malosh RE, Martin ET, Callear AP, et al. Respiratory syncytial virus hospitalization in middle-aged and older adults. J Clin Virol. 2017;1(96):37\u201343.","journal-title":"J Clin Virol"},{"issue":"11","key":"1295_CR24","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/cid\/ciad031","volume":"76","author":"KM Begley","year":"2023","unstructured":"Begley KM, Monto AS, Lamerato LE, et al. Prevalence and clinical outcomes of respiratory syncytial virus vs influenza in adults hospitalized with acute respiratory illness from a prospective multicenter study. Clin Infect Dis. 2023;76(11):1980\u20138.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1295_CR25","doi-asserted-by":"publisher","first-page":"e0214517","DOI":"10.1371\/journal.pone.0214517","volume":"14","author":"R Cohen","year":"2019","unstructured":"Cohen R, Babushkin F, Geller K, Finn T. Characteristics of hospitalized adult patients with laboratory documented influenza\u00a0A, B and respiratory syncytial virus\u2014a single center retrospective observational study. PLoS ONE. 2019;14(3):e0214517.","journal-title":"PLoS ONE"},{"issue":"11","key":"1295_CR26","doi-asserted-by":"publisher","first-page":"ofad513","DOI":"10.1093\/ofid\/ofad513","volume":"10","author":"A Njue","year":"2023","unstructured":"Njue A, Nuabor W, Lyall M, et al. Systematic literature review of risk factors for poor outcomes among adults with respiratory syncytial virus infection in high-income countries. Open Forum Infect Dis. 2023;10(11):ofad513.","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"1295_CR27","doi-asserted-by":"publisher","first-page":"ofy316","DOI":"10.1093\/ofid\/ofy316","volume":"5","author":"EA Belongia","year":"2018","unstructured":"Belongia EA, King JP, Kieke BA, et al. Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults \u226560\u00a0years old. Open Forum Infect Dis. 2018;5(12):ofy316.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"1295_CR28","doi-asserted-by":"publisher","first-page":"e70373","DOI":"10.1002\/jmv.70373","volume":"97","author":"G Trifonov","year":"2025","unstructured":"Trifonov G, B\u00fcscher E, Fistera D, et al. Disease burden of RSV infection in adult patients in comparison to influenza virus infection. J Med Virol. 2025;97(5):e70373.","journal-title":"J Med Virol"},{"key":"1295_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2025.2450590","author":"N Inoue","year":"2025","unstructured":"Inoue N, Nagai H, Fushimi K. Severity and outcomes of adult respiratory syncytial virus inpatient compared with influenza: observational study from Japan. Infect Dis (Lond). 2025. https:\/\/doi.org\/10.1080\/23744235.2025.2450590.","journal-title":"Infect Dis (Lond)"},{"key":"1295_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060624","author":"LM Stephens","year":"2021","unstructured":"Stephens LM, Varga SM. Considerations for a respiratory syncytial virus vaccine targeting an elderly population. Vaccines. 2021. https:\/\/doi.org\/10.3390\/vaccines9060624.","journal-title":"Vaccines"},{"issue":"8","key":"1295_CR31","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/infdis\/jiaa361","volume":"222","author":"HF Tseng","year":"2020","unstructured":"Tseng HF, Sy LS, Ackerson B, et al. Severe morbidity and short-and mid-to long-term mortality in older adults hospitalized with respiratory syncytial virus infection. J Infect Dis. 2020;222(8):1298\u2013310.","journal-title":"J Infect Dis"},{"issue":"95","key":"1295_CR32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ijid.2020.04.020","volume":"1","author":"R Bruyndonckx","year":"2020","unstructured":"Bruyndonckx R, Coenen S, Butler C, et al. Respiratory syncytial virus and influenza virus infection in adult primary care patients: association of age with prevalence, diagnostic features and illness course. Int J Infect Dis. 2020;1(95):384\u201390.","journal-title":"Int J Infect Dis"},{"key":"1295_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01230-3","author":"V Wyffels","year":"2020","unstructured":"Wyffels V, Kariburyo F, Gavart S, Fleischhackl R, Yuce H. A real-world analysis of patient characteristics and predictors of hospitalization among US medicare beneficiaries with respiratory syncytial virus infection. Adv Ther. 2020. https:\/\/doi.org\/10.1007\/s12325-020-01230-3.","journal-title":"Adv Ther"},{"issue":"6","key":"1295_CR34","doi-asserted-by":"publisher","first-page":"e0234235","DOI":"10.1371\/journal.pone.0234235","volume":"15","author":"N Prasad","year":"2020","unstructured":"Prasad N, Newbern EC, Trenholme AA, et al. The health and economic burden of respiratory syncytial virus associated hospitalizations in adults. PLoS ONE. 2020;15(6):e0234235.","journal-title":"PLoS ONE"},{"issue":"14","key":"1295_CR35","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.jacc.2018.02.013","volume":"71","author":"KS Ivey","year":"2018","unstructured":"Ivey KS, Edwards KM, Talbot HK. Respiratory syncytial virus and associations with cardiovascular disease in adults. J Am Coll Cardiol. 2018;71(14):1574\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1295_CR36","doi-asserted-by":"publisher","first-page":"e2111806","DOI":"10.1001\/jamanetworkopen.2021.11806","volume":"4","author":"E Bosco","year":"2021","unstructured":"Bosco E, Van Aalst R, McConeghy KW, et al. Estimated cardiorespiratory hospitalizations attributable to influenza and respiratory syncytial virus among long-term care facility residents. JAMA Netw Open. 2021;4(6):e2111806.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1295_CR37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jamainternmed.2024.0212","volume":"184","author":"RC Woodruff","year":"2024","unstructured":"Woodruff RC, Melgar M, Pham H, et al. Acute cardiac events in hospitalized older adults with respiratory syncytial virus infection. JAMA Intern Med. 2024;184(6):602\u201311.","journal-title":"JAMA Intern Med"},{"key":"1295_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122092","author":"S Maggi","year":"2022","unstructured":"Maggi S, Veronese N, Burgio M, et al. Rate of hospitalizations and mortality of respiratory syncytial virus infection compared to influenza in older people: a systematic review and meta-analysis. Vaccines. 2022. https:\/\/doi.org\/10.3390\/vaccines10122092.","journal-title":"Vaccines"},{"issue":"110","key":"1295_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijid.2021.07.045","volume":"1","author":"B Chuaychoo","year":"2021","unstructured":"Chuaychoo B, Rattanasaengloet K, Banlengchit R, et al. Characteristics, complications, and mortality of respiratory syncytial virus compared with influenza infections in hospitalized adult patients in Thailand. Int J Infect Dis. 2021;1(110):237\u201346.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"1295_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106570","volume":"91","author":"R Symes","year":"2025","unstructured":"Symes R, Keddie SH, Walker J, et al. Burden of respiratory syncytial virus infection in older adults hospitalised in England during 2023\/24. J Infect. 2025;91(3):106570.","journal-title":"J Infect"},{"key":"1295_CR41","first-page":"161","volume":"1","author":"A Andreas","year":"2023","unstructured":"Andreas A, Doris L, Frank K, Michael K. Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza\u00a0A \/ B and the original SARS-CoV-2 strain. J Clin Virol. 2023;1:161.","journal-title":"J Clin Virol"},{"issue":"2","key":"1295_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/cid\/ciy991","volume":"69","author":"B Ackerson","year":"2019","unstructured":"Ackerson B, Tseng HF, Sy LS, et al. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69(2):197\u2013203.","journal-title":"Clin Infect Dis"},{"key":"1295_CR43","first-page":"55","volume":"1","author":"LE Wee","year":"2025","unstructured":"Wee LE, Lim JT, Ho RWL, et al. Severity of respiratory syncytial virus versus SARS-CoV-2 Omicron and influenza infection amongst hospitalized Singaporean adults: a national cohort study. Lancet Reg Health West Pac. 2025;1:55.","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"1295_CR44","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s41999-024-01066-y","volume":"15","author":"AC Moreira","year":"2024","unstructured":"Moreira AC, Ribeiro AB, Oliveira I, S\u00e1 M, Lameir\u00e3o C, Marques P. Efficacy of anti-RSV vaccination in preventing respiratory syncytial virus disease and severe illness in older adults: a systematic review of randomized controlled trials. Eur Geriatr Med. 2024;15(5):1215\u201329.","journal-title":"Eur Geriatr Med"},{"issue":"5","key":"1295_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.8322","volume":"8","author":"SE Fry","year":"2025","unstructured":"Fry SE, Terebuh P, Kaelber DC, Xu R, Davis PB. Effectiveness and safety of respiratory syncytial virus vaccine for US adults aged 60\u00a0years or older. JAMA Netw Open. 2025;8(5):e258322.","journal-title":"JAMA Netw Open"},{"issue":"10462","key":"1295_CR46","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(24)01738-0","volume":"404","author":"AB Payne","year":"2024","unstructured":"Payne AB, Watts JA, Mitchell PK, et al. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60\u00a0years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. Lancet. 2024;404(10462):1547\u201359.","journal-title":"Lancet"},{"issue":"3","key":"1295_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1473-3099(25)00064-7","volume":"25","author":"SS Hameed","year":"2025","unstructured":"Hameed SS, Robertson C, Morrison K, et al. Early evidence of RSV vaccination impact on hospitalisation rates of older people in Scotland. Lancet Infect Dis. 2025;25(3):256\u20138.","journal-title":"Lancet Infect Dis"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01295-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01295-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01295-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:34:18Z","timestamp":1777484058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01295-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1295"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01295-z","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dafna Yahav is conducting an investigator-initiated study supported by Shionogi (funding to the institution). Dafna Yahav is an Editorial Board member of\n                      Infectious Diseases and Therapy\n                      , but was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Menucha Jurkowicz, Ili Margalit, Itai Harris, Daniel Mazar, Arad Teper, Irena Royzman, Sonal Uppal, Caihua Liang, Elizabeth Begier, Imri Ganiel & Michal Mandelboim have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study was approved by Sheba Medical Center\u2019s institutional review board (approval no. SMC-0218-23), and was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All data were fully anonymized prior to analysis, with no identifiable patient information retained. The institutional review board granted a waiver of informed consent, as the study involved analysis of de-identified data and posed minimal risk to participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}